PAR 2.63% 19.5¢ paradigm biopharmaceuticals limited..

PAR Broker Data, page-56

  1. 1,749 Posts.
    lightbulb Created with Sketch. 115
    I am just going thru the slides and comparing the data against my winners.

    I am also assuming their target is Osteoarthritis which has a market of 9 billion in the last slide. Let me know if this is incorrect.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.